Search Results

Raltegravir 25 mg  | 99.05%

TargetMol

Raltegravir is a pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION.

More Information Supplier Page

Raltegravir 10 mg  | 99.05%

TargetMol

Raltegravir is a pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION.

More Information Supplier Page

JNJ-7777120 5 mg  | Purity Not Available

TargetMol

JNJ-7777120 is the first potent and selective non-imidazole histamine H4 receptor antagonist with Ki of 4.5 nM, exhibits >1000-fold selectivity over the other histamin receptors.

More Information Supplier Page

JNJ-7777120 50 mg  | Purity Not Available

TargetMol

JNJ-7777120 is the first potent and selective non-imidazole histamine H4 receptor antagonist with Ki of 4.5 nM, exhibits >1000-fold selectivity over the other histamin receptors.

More Information Supplier Page

JNJ-7777120 10 mg  | Purity Not Available

TargetMol

JNJ-7777120 is the first potent and selective non-imidazole histamine H4 receptor antagonist with Ki of 4.5 nM, exhibits >1000-fold selectivity over the other histamin receptors.

More Information Supplier Page

JNJ-7777120 100 mg  | Purity Not Available

TargetMol

JNJ-7777120 is the first potent and selective non-imidazole histamine H4 receptor antagonist with Ki of 4.5 nM, exhibits >1000-fold selectivity over the other histamin receptors.

More Information Supplier Page

Raltegravir 50 mg  | 99.05%

TargetMol

Raltegravir is a pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION.

More Information Supplier Page

Raltegravir 5 mg  | 99.05%

TargetMol

Raltegravir is a pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION.

More Information Supplier Page